Aetion President Kevin Riley joined Nasdaq’s Kristina Ayanian at HLTH USA to discuss how Aetion is driving critical healthcare decisions through data science-driven technology. In this insightful conversation, Kevin shares his excitement about the future of real-world evidence and its potential impact on patients, pharmaceutical companies, payers, and beyond.
Watch now to explore how Aetion is shaping the future of healthcare.